Quantamental Technologies LLC Innoviva, Inc. Transaction History

Quantamental Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $108,179 - $137,115	10,082 New	10,082 $113,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $33,451 - $46,439	-2,336 Reduced 16.02%	12,246 $181,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $224,416 - $295,285	14,582 New	14,582 $282,000
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $48,481 - $70,189	-4,824 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.1 - $14.95 $63,194 - $72,118	4,824 New	4,824 $70,000
Q1 2019 Apr 29, 2019	SELL	$13.69 - $20.06 $134,613 - $197,249	-9,833 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$13.96 - $18.26 $137,268 - $179,550	9,833 New	9,833 $172,000

226

78.7M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.31B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.